Solicitation of Nominations for Appointment to the Board of Scientific Counselors (BSC), National Institute for Occupational Safety and Health (NIOSH), 7056-7057 [2019-03666]

Download as PDF 7056 Federal Register / Vol. 84, No. 41 / Friday, March 1, 2019 / Notices Board of Governors of the Federal Reserve System, February 26, 2019. Ann Misback, Secretary of the Board. [FR Doc. 2019–03687 Filed 2–28–19; 8:45 am] BILLING CODE 6210–01–P GENERAL SERVICES ADMINISTRATION [Notice–PBS–2018–07; Docket No. 2018– 0002; Sequence No. 21] Redesignation of Federal Building Public Buildings Service (PBS), General Services Administration (GSA). ACTION: Notice of a bulletin. AGENCY: SUMMARY: The attached bulletin announces the redesignation of a Federal building per the Federal Management Regulation. DATES: This bulletin expires September 3, 2019. The building redesignation remains in effect until canceled or superseded by another bulletin. FOR FURTHER INFORMATION CONTACT: General Services Administration, Public Buildings Service (PBS), Office of Portfolio Management, Attn: Chandra Kelley, 77 Forsyth Street SW, Atlanta, GA 30303, at 404–562–2763, or by email at chandra.kelley@gsa.gov. SUPPLEMENTARY INFORMATION: This bulletin announces the redesignation of a Federal building. Public Law 115–141, Section 632, dated January 3, 2017, designated the Jackson Federal Courthouse, located at 501 East Court Street in Jackson, Mississippi, as the ‘‘Thad Cochran United States Courthouse.’’ Dated: February 22, 2019. Emily W. Murphy, Administrator of General Services. GENERAL SERVICES ADMINISTRATION jbell on DSK30RV082PROD with NOTICES REDESIGNATION OF FEDERAL BUILDING PBS-2018-07 TO: Heads of Federal Agencies. SUBJECT: Redesignation of Federal Building. 1. What is the purpose of this bulletin? This bulletin announces the redesignation of a Federal building. 2. When does this bulletin expire? This bulletin announcement expires September 3, 2019. The building designation remains in effect until canceled or superseded by another bulletin. 3. Redesignation. The former and new name of the redesignated building is as follows: VerDate Sep<11>2014 18:13 Feb 28, 2019 Jkt 247001 Former name New name Jackson Federal Courthouse, 501 East Court Street in Jackson, Mississippi, 39201. Thad Cochran United States Courthouse, 501 East Court Street in Jackson, Mississippi, 39201. 4. Who should we contact for further information regarding redesignation of this Federal building? U.S. General Services Administration, Public Buildings Service, Office of Portfolio Management, Attn: Chandra Kelley, 77 Forsyth Street, SW, Atlanta, GA 30303, telephone number: 404-562-2763, or email at chandra.kelley@gsa.gov. Dated: February 22, 2019. Emily W. Murphy, Administrator of General Services. [FR Doc. 2019–03711 Filed 2–28–19; 8:45 am] BILLING CODE 6820–Y1–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Board of Scientific Counselors (BSC), National Institute for Occupational Safety and Health (NIOSH) ACTION: Notice. SUMMARY: The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the BSC, NIOSH. The BSC, NIOSH consists of 15 experts in fields associated with occupational safety and health. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of occupational medicine, occupational nursing, industrial hygiene, occupational safety and health engineering, toxicology, chemistry, safety and health education, ergonomics, epidemiology, biostatistics, and psychology. Federal employees will not be considered for membership. Members may be invited to serve for up to four-year terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of the BSC, NIOSH objectives https://www.cdc.gov/ niosh/BSC/default.html. DATES: Nominations for membership on the BSC, NIOSH must be received no later than April 30, 2019. Packages received after this time will not be PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NIOSH Docket 278, c/o Pauline Benjamin, Committee Management Specialist, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, MS: E– 20, Atlanta, Georgia 30329 or emailed (recommended) to nioshdocket@ cdc.gov. FOR FURTHER INFORMATION CONTACT: Alberto Garcia, M.S., Designated Federal Officer, CDC/NIOSH, 1090 Tusculum Ave. MS R–5, Cincinnati, OH 45226, telephone (513) 841–4596; agarcia1@ cdc.gov. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees (SGEs), requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for BSC, NIOSH membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in January, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D Cover letter, including a description of the candidate qualifications and why the candidate would be a good fit for the BSC. E:\FR\FM\01MRN1.SGM 01MRN1 Federal Register / Vol. 84, No. 41 / Friday, March 1, 2019 / Notices D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–03666 Filed 2–28–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3376–N] Medicare Program; Solicitation of Independent Accrediting Organizations To Participate in the Home Infusion Therapy Supplier Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. jbell on DSK30RV082PROD with NOTICES AGENCY: SUMMARY: This notice informs national accrediting organizations that accredit home infusion therapy suppliers of an opportunity to submit applications to participate in the home infusion therapy supplier accreditation program. This notice contains information on how to apply for CMS approval. DATES: Complete applications will be considered for the January 1, 2021 designation deadline if received at the address, provided in the ADDRESSES section of this notice, by 5 p.m. eastern daylight time (e.d.t.) on February 1, 2020. ADDRESSES: Applications should be sent to: Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244. Mail stop C2–21–16, Attention: Christina MisterWard. FOR FURTHER INFORMATION CONTACT: Christina Mister-Ward (410) 786–2441. VerDate Sep<11>2014 18:13 Feb 28, 2019 Jkt 247001 SUPPLEMENTARY INFORMATION: I. Background Section 1861(iii)(1) of the Social Security Act (‘‘the Act’’) defines ‘‘home infusion therapy’’ as the items and services described furnished by a qualified home infusion therapy supplier which are furnished in the individual’s home. The individual must be— • Under the care of an applicable provider; and • With respect to whom a plan prescribing the type, amount, and duration of infusion therapy services that are to be furnished such individual has been established by a physician and is periodically reviewed by a physician in coordination with the furnishing of home infusion drugs under part B. According to section 1861(iii)(3)(A) of the Act, ‘‘Applicable provider’’ means a physician, a nurse practitioner, or a physician assistant. In accordance with section 1834(u)(5) of the Act, we defined ‘‘National accrediting organization’’ at 42 CFR 488.1005 as an organization that accredits provider or supplier entities under a specific program and whose accredited provider or supplier entities under each program are widely dispersed geographically across the United States. In addition, the specific program is active, fully implemented, and operational. In the November 13, 2018 Federal Register (83 FR 56406),we published a final rule titled, ‘‘Medicare and Medicaid Programs; CY 2019 Home Health Prospective Payment System Rate Update and CY 2020 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; Home Infusion Therapy Requirements; and Training Requirements for Surveyors of National Accrediting Organizations.’’ The November 2018 final rule implemented health and safety standards that home infusion therapy suppliers must meet; the temporary transitional payments for home infusion therapy services for CYs 2019; and an approval and oversight process for accrediting organizations (AOs) that accredit home infusion therapy suppliers. For more detailed information on the home therapy organization accreditation requirements see the November 2018 final rule (83 FR 56563 through 56584). Section 1861(iii)(3)(D)(i)(III) of the Act, as added by section 5012(b) of the 21st Century Cures Act, requires that a home infusion therapy supplier be accredited by an AO designated by the Secretary in accordance with section 1834(u)(5) of the Act. Section PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 7057 1834(u)(5)(A) of the Act identifies factors for designating AOs and modifying the list of designated AOs. These statutory factors are as follows: • The ability of the organization to conduct timely reviews of accreditation applications. • The ability of the organization take into account the capacities of suppliers located in a rural area (as defined in section 1886(d)(2)(D) of the Act). • Whether the organization has established reasonable fees to be charged to suppliers applying for accreditation. • Such other factors as the Secretary determines appropriate. Section 1834(u)(5)(B) of the Act requires the Secretary to designate AOs to accredit home infusion therapy suppliers furnishing home infusion therapy not later than January 1, 2021. II. Provisions of the Notice This notice solicits applications from AOs with the ability to accredit home infusion therapy suppliers. A. Eligible Organizations An accreditation organization that can show evidence of the ability to accredit qualified home infusion therapy suppliers as defined in section 1861(iii)(3)(D)(i) of the Act are eligible to apply for approval as a designated accreditation organization. To be considered for approval as a Medicare-designated home infusion therapy AO under 42 CFR part 488, subpart L (§§ 488.1000 through 488.1050), an accrediting organization must meet the following requirements: • The AO must have a home infusion therapy accreditation program that it separates and distinguishes from any of its other accreditation programs (if applicable). • The AO must have home infusion therapy accreditation standards that meet or exceed the Medicare home infusion therapy health and safety standards codified at §§ 486.500 through 486.525 of our regulations. B. Application Requirements To be considered for approval by Medicare as a home infusion therapy accrediting organization, an accrediting organization must submit an application to CMS requesting approval of its home infusion therapy accreditation program. The home infusion therapy accrediting organization’s application must contain all of the following information to demonstrate that the AO’s home infusion therapy accreditation program meets or exceeds the applicable Medicare requirements: • Documentation to demonstrate that they meet the definition of a ‘‘national E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 84, Number 41 (Friday, March 1, 2019)]
[Notices]
[Pages 7056-7057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03666]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Board of 
Scientific Counselors (BSC), National Institute for Occupational Safety 
and Health (NIOSH)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the BSC, NIOSH. The BSC, NIOSH 
consists of 15 experts in fields associated with occupational safety 
and health.
    Nominations are being sought for individuals who have expertise and 
qualifications necessary to contribute to the accomplishments of the 
committee's objectives. Nominees will be selected based on expertise in 
the fields of occupational medicine, occupational nursing, industrial 
hygiene, occupational safety and health engineering, toxicology, 
chemistry, safety and health education, ergonomics, epidemiology, 
biostatistics, and psychology. Federal employees will not be considered 
for membership. Members may be invited to serve for up to four-year 
terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of the BSC, NIOSH objectives https://www.cdc.gov/niosh/BSC/default.html.

DATES: Nominations for membership on the BSC, NIOSH must be received no 
later than April 30, 2019. Packages received after this time will not 
be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to NIOSH Docket 278, c/o 
Pauline Benjamin, Committee Management Specialist, National Institute 
for Occupational Safety and Health, Centers for Disease Control and 
Prevention, 1600 Clifton Rd. NE, MS: E-20, Atlanta, Georgia 30329 or 
emailed (recommended) to nioshdocket@cdc.gov.

FOR FURTHER INFORMATION CONTACT: Alberto Garcia, M.S., Designated 
Federal Officer, CDC/NIOSH, 1090 Tusculum Ave. MS R-5, Cincinnati, OH 
45226, telephone (513) 841-4596; agarcia1@cdc.gov.

SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human 
Services policy stipulates that committee membership be balanced in 
terms of points of view represented, and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens, and cannot be full-time employees of 
the U.S. Government. Current participation on federal workgroups or 
prior experience serving on a federal advisory committee does not 
disqualify a candidate; however, HHS policy is to avoid excessive 
individual service on advisory committees and multiple committee 
memberships. Committee members are Special Government Employees (SGEs), 
requiring the filing of financial disclosure reports at the beginning 
and annually during their terms. CDC reviews potential candidates for 
BSC, NIOSH membership each year, and provides a slate of nominees for 
consideration to the Secretary of HHS for final selection. HHS notifies 
selected candidates of their appointment near the start of the term in 
January, or as soon as the HHS selection process is completed. Note 
that the need for different expertise varies from year to year and a 
candidate who is not selected in one year may be reconsidered in a 
subsequent year. SGE Nominees must be U.S. citizens, and cannot be 
full-time employees of the U.S. Government. Candidates should submit 
the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] Cover letter, including a description of the candidate 
qualifications and why the candidate would be a good fit for the BSC.

[[Page 7057]]

    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities for both CDC and the Agency for Toxic Substances 
and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-03666 Filed 2-28-19; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.